10212017Headline:

St. Petersburg, Florida

HomeFloridaSt. Petersburg

Email Joseph H. Saunders Joseph H. Saunders on LinkedIn Joseph H. Saunders on Facebook Joseph H. Saunders on Avvo
Joseph H. Saunders
Joseph H. Saunders
Attorney • (800) 748-7115

Respiratory Inhaler May Pose Greater Stroke Risk

Comments Off

The FDA is looking into whether Boehringer Ingelheim’ respiratory inhaler poses a greater risk of stroke. According to the FDA, the data submitted by the German drug manufacturer, shows that its Spiriva Handihaler poses a greater risk of stroke compared with a placebo. FDA said it has not yet analyzed the figures, which were compiled from 29 patient studies. The FDA has asked doctors to report any adverse patient results while it waits for more data from the company in June.